면역분석법 시장 : 전략과 동향 - 용도별, 기술별, 제품별, 사용자별, 국가별 예측 - 이그제큐티브 컨설턴트 가이드와 인공지능의 영향(2025-2029년)

Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive and Consultant Guides. 2025 to 2029. Includes Impact of Artificial Intelligence.

US $ 6,995 ￦ 9,771,000

PDF (Single User License)

PDF 보고서를 1명(One device)만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,495 ￦ 14,660,000

PDF (Five User License)

PDF 보고서를 동일 사업장의 5명(Five devices)까지 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 13,995 ￦ 19,549,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

보고서 개요

진단약 업계의 주력 제품이 새로운 각광을 받고 있습니다. 팬데믹은 신속하고 쉽게 구할 수 있는 진단약에 대한 새로운 수요를 창출했습니다. 면역 분석은 그 중 한 축을 담당하고 있습니다. 위협과 기회가 넘쳐나고 있습니다. 유전자에 대한 지식의 발전은 면역 분석법에 대한 새로운 시장을 창출하고 있습니다. 멀티플렉스는 필수품이 되어가고 있습니다. 신속진단, 현장진단, 바이오마커, 소비자 시장은 모두 기존 면역분석에 영향을 미치는 분야입니다. 이 분야에서 활약하는 기업 80개 이상을 소개합니다. 이 방대한 보고서에서 함정과 기회에 대한 모든 것을 배울 수 있습니다.

최신 데이터를 통해 투자 판단과 밸류에이션에 대한 확신을 가질 수 있습니다.

세계의 면역분석법 시장에 대해 조사했으며, 시장의 개요와 용도별, 기술별, 제품별, 사용자별, 국가별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.

목차

제1장 시장 가이드

제2장 서론과 시장의 정의

• 이 보고서에서 면역분석법 시장의 정의
• 시장 정의
• 조사 방법
• 시점 : 헬스케어와 IVD 업계

제3장 업계 개요

• 시장 참여 조직
  • 학술연구기관
  • 진단 시험 개발자
  • 계측 기기 공급업체
  • 약품·시약 제조업체
  • 병리 공급업체
  • 독립계 임상 검사실
  • 공공 국립/지역 연구소
  • 병원 검사실
  • 임상 검사실
  • 감사 기관
  • 인증 기관
• 임상 검사 시장의 부문
• 면역분석법 - 시장과 논의

제4장 시장 동향

• 성장 촉진요인
• 성장 억제요인
• 면역분석법 기기

제5장 면역분석법의 최근 동향

제6장 주요 기업의 개요

• Abbott Laboratories
• Abcam
• Abionic
• Accel Diagnostics
• Agilent
• Akonni Biosystems
• Applied BioCode
• Arlington Scientific
• Arrayit Corporation
• Atomo Diagnostics
• Aureum Diagnostics
• Aurora Biomed
• Autobio Diagnostics
• AVIVA Systems Biology
• Awareness Technology
• Axis-Shield Diagnostics Ltd.
• Beckman Coulter Diagnostics(Danaher)
• Becton, Dickinson and Company
• Biocartis
• Biomatik
• bioMerieux Diagnostics
• Bioneer Corporation
• Bio-Rad Laboratories, Inc.
• Bio-Synthesis
• Bio-Techne
• Boditech Med, Inc
• Boster Biological Technology
• Bruker
• Cerstest Biotec
• Chembio
• CTK Biotech
• Cue Health
• Cytena
• Diasorin S.p.A.
• Dynex Technologies
• Eiken Chemical
• Enzo Biochem
• Eurofins Scientific
• Fluxion Biosciences(Cell Microsystems)
• FUJIFILM Wako Diagnostics
• Fujirebio
• Global Access Diagnostics
• Gold Standard Diagnostics
• Greiner Bio-One
• Grifols
• Hycor Biomedical
• Immunodiagnostic Systems(IDS)
• Iollo
• JR Biomedical
• LightDeck Diagnostics
• LumiraDx
• Maxim Biomedical
• Meso Scale Discovery
• Millipore Sigma
• Mindray
• Molecular Devices
• MP Biomedical
• Operon
• OraSure Technologies
• Qiagen
• QuidelOrtho
• R&D Systems
• Randox Toxicology
• R-Biopharm AG
• Response Biomedical
• Revvity
• Roche Diagnostics
• SD Biosensor
• Siemens Healthineers
• Standard BioTools
• Sysmex
• Tecan
• Thermo Fisher Scientific
• TOSOH Bioscience
• Uniogen
• Veramarx
• Veredus Laboratories
• Vircell
• Wantai Biopharm
• Werfen
• YD Diagnostics
• Zhejiang Orient Gene Biotech

제7장 세계 시장

• 국가별 세계 시장
• 용도별 세계 시장
• 기술별 세계 시장
• 제품별 세계 시장
• 사용자별 세계 시장

제8장 용도별 세계 시장

• 내분비학
• 면역
• 종양학
• 감염증
• 심장병학
• 기타

제9장 기술별 세계 시장

• 효소
• 형광
• 화학 발광
• 핵산
• 신속/POC
• 기타

제10장 제품별 세계 시장

• 기기
• 시약
• 서비스

제11장 사용자별 세계 시장

• 병원
• 외래 검사실
• POC/기타

제12장 면역분석법의 향후 비전

제13장 부록

KSA

영문 목차

영문목차

Report Overview:

The workhorse of the diagnostic industry is finding new legs. The pandemic has created a new demand for rapid easily available diagnostics. Immunoassay is stepping up. Threats and opportunities abound. Advances in genetic knowledge are creating new markets for immunoassay. Multiplex is becoming table stakes. Rapid diagnostics, point of care, biomarkers and consumer markets are all areas affecting traditional immunoassay. We profile over 80 companies, working in this area. Learn all about the pitfalls and opportunities in this extensive report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

Table of Contents

1. Market Guides

• 1.1. Immunoassay Market - Strategic Situation Analysis
• 1.2. Guide for Executives, Marketing, Sales and Business Development Staff
• 1.3. Guide for Management Consultants and Investment Advisors
• 1.4. Impact of Artificial Intelligence

2. Introduction and Market Definition

• 2.1. Immunoassay Markets Definition In This Report
  • 2.1.1. Enzyme Based
  • 2.1.2. Immunofluorescence
  • 2.1.3. Chemiluminescence
  • 2.1.4. DNA/NAT
  • 2.1.5. RIA & Other
  • 2.1.6. Reagents/Kits, Analyzers, Software & Services
  • 2.1.7. Infectious Disease
  • 2.1.8. Auto Immune
  • 2.1.9. Endocrinology
  • 2.1.10. Oncology
  • 2.1.11. Cardiology
  • 2.1.12. Other Specialty
• 2.2. Market Definition
  • 2.2.1. Market Sizes
  • 2.2.2. Currency
  • 2.2.3. Years
• 2.3. Methodology
  • 2.3.1. Methodology
  • 2.3.2. Sources
  • 2.3.3. Authors
• 2.4. Perspective: Healthcare and the IVD Industry
  • 2.4.1. Global Healthcare Spending
  • 2.4.2. Spending on Diagnostics
  • 2.4.3. Important Role of Insurance for Diagnostics

3. Industry Overview

• 3.1. Players in a Dynamic Market
  • 3.1.1. Academic Research Lab
  • 3.1.2. Diagnostic Test Developer
  • 3.1.3. Instrumentation Supplier
  • 3.1.4. Chemical/Reagent Supplier
  • 3.1.5. Pathology Supplier
  • 3.1.6. Independent Clinical Laboratory
  • 3.1.7. Public National/regional Laboratory
  • 3.1.8. Hospital Laboratory
  • 3.1.9. Physicians Office Lab (POLS)
  • 3.1.10. Audit Body
  • 3.1.11. Certification Body
• 3.2. The Clinical Laboratory Market Segments
  • 3.2.1. Traditional Market Segmentation
  • 3.2.2. Laboratory Focus and Segmentation
  • 3.2.3. Hospital Testing Share
  • 3.2.4. Economies of Scale
  • 3.2.5. Hospital vs. Central Lab
  • 3.2.6. Physician Office Lab's
  • 3.2.7. Physician's and POCT
• 3.3. Immunoassay -Markets and Discussion
  • 3.3.1. Instruments - Genetics changes the picture
    • 3.3.1.1. RIA - A Technology Shows its Age
    • 3.3.1.2. Immunoassay vs. PCR vs. Sequencing - A See Saw Battle
    • 3.3.1.3. The Smart Shrinking Instrument - Serious Implications
    • 3.3.1.4. Research Funding and Capital Expense - Instrument Pooling
    • 3.3.1.5. Multiplex vs. POC - A Tradeoff Analysis
  • 3.3.2. Reagents and Kits - Genetics changes the picture
    • 3.3.2.1. Bigger Test Menus a Boon for Kit Market
    • 3.3.2.2. Physician Office Labs - A New Frontier
  • 3.3.3. Rapid and POCT to Threaten Instrument Markets
  • 3.3.4. OTC and DTC - Huge Market Potential
  • 3.3.5. Economies of Scale. Going Away?
  • 3.3.6. Lower Barriers to Entry for Instruments/Analyzers
  • 3.3.7. Miniturization and Technology Drive Acquisition

4. Market Trends

• 4.1. Factors Driving Growth
  • 4.1.1. Diagnostic Factors
  • 4.1.2. Changing Technologies Spur Early Instrument Retirement
  • 4.1.3. Consumer Channels Open Wider
  • 4.1.4. Immunity Technology Comes of Age
• 4.2. Factors Limiting Growth
  • 4.2.1. Increased Competition Lowers Price
  • 4.2.2. Threat from PCR Based Instruments
  • 4.2.3. Lower Barriers to Entry
  • 4.2.4. Wellness has a downside
• 4.3. Immunoassay Instrumentation
  • 4.3.1. Instrumentation Tenacity
  • 4.3.2. Declining Cost of Instruments Changes Industry Structure
  • 4.3.3. Immunoassay - CRISPR Diagnostics

5. Immunoassay Recent Developments

• 5.1. Recent Developments - Importance and How to Use This Section
  • 5.1.1. Importance of These Developments
  • 5.1.2. How to Use This Section
• 5.2. Beckman Coulter Dx Analyzer Gets FDA Clearance
• 5.3. Cubit Diagnostics Gets NIH Funding for Test on Multimodal Platform
• 5.4. Medix Biochemica Acquires Candor Bioscience
• 5.5. Siemens Healthineers Dx Business Poised for Growth
• 5.6. QuidelOrtho Stock Upgraded
• 5.7. AliveDx Gets CE Mark for Allergy Immunoassay
• 5.8. FDA Grants EAU for At-Home COVID, Flu Assay
• 5.9. Single-Molecule Detection Tech Shows Promise
• 5.10. QuidelOrtho Vitros Fentanyl Test
• 5.11. Labcorp: Plasma Phosphorylated-Tau 217
• 5.12. Renalytix Gets Immunoassay Medicare Coverage
• 5.13. Roche to Acquire LumiraDx POC Tech
• 5.14. Fujirebio, Sysmex to Collaborate on Immunoassay Development
• 5.15. EDP Biotech, New Day Diagnostics to Merge
• 5.16. Sorrento Therapeutics Nabs Contract for Dx Platform
• 5.17. Beckman Coulter Diagnostics DxI 9000 Access Immunoassay Analyzer
• 5.18. Qorvo Eyes Multiplex Immunoassay
• 5.19. BioMerieux Launches New Products
• 5.20. Senzo to Commercialize Infectious Disease Lateral Flow Tests
• 5.21. Nanomix Plans Instrument, Test Launches
• 5.22. Startup GLX Analytix Prepares for Commercialization
• 5.23. Nonagen Gets CE Mark for Bladder Cancer Immunoassay
• 5.24. Qualigen Acquires Majority Stake in NanoSynex
• 5.25. Saladax Biomedical Using Immunoassay Dx
• 5.26. Prolight Diagnostics to Acquire Psyros Diagnostics
• 5.27. Quidel to Acquire Ortho Clinical Diagnostics

6. Profiles of Key Companies

• 6.1. Abbott Laboratories
• 6.2. Abcam
• 6.3. Abionic
• 6.4. Accel Diagnostics
• 6.5. Agilent
• 6.6. Akonni Biosystems
• 6.7. Applied BioCode
• 6.8. Arlington Scientific
• 6.9. Arrayit Corporation
• 6.10. Atomo Diagnostics
• 6.11. Aureum Diagnostics
• 6.12. Aurora Biomed
• 6.13. Autobio Diagnostics
• 6.14. AVIVA Systems Biology
• 6.15. Awareness Technology
• 6.16. Axis-Shield Diagnostics Ltd.
• 6.17. Beckman Coulter Diagnostics (Danaher)
• 6.18. Becton, Dickinson and Company
• 6.19. Biocartis
• 6.20. Biomatik
• 6.21. bioMerieux Diagnostics
• 6.22. Bioneer Corporation
• 6.23. Bio-Rad Laboratories, Inc.
• 6.24. Bio-Synthesis
• 6.25. Bio-Techne
• 6.26. Boditech Med, Inc
• 6.27. Boster Biological Technology
• 6.28. Bruker
• 6.29. Cerstest Biotec
• 6.30. Chembio
• 6.31. CTK Biotech
• 6.32. Cue Health
• 6.33. Cytena
• 6.34. Diasorin S.p.A.
• 6.35. Dynex Technologies
• 6.36. Eiken Chemical
• 6.37. Enzo Biochem
• 6.38. Eurofins Scientific
• 6.39. Fluxion Biosciences (Cell Microsystems)
• 6.40. FUJIFILM Wako Diagnostics
• 6.41. Fujirebio
• 6.42. Global Access Diagnostics
• 6.43. Gold Standard Diagnostics
• 6.44. Greiner Bio-One
• 6.45. Grifols
• 6.46. Hycor Biomedical
• 6.47. Immunodiagnostic Systems (IDS)
• 6.48. Iollo
• 6.49. JR Biomedical
• 6.50. LightDeck Diagnostics
• 6.51. LumiraDx
• 6.52. Maxim Biomedical
• 6.53. Meso Scale Discovery
• 6.54. Millipore Sigma
• 6.55. Mindray
• 6.56. Molecular Devices
• 6.57. MP Biomedical
• 6.58. Operon
• 6.59. OraSure Technologies
• 6.60. Qiagen
• 6.61. QuidelOrtho
• 6.62. R&D Systems
• 6.63. Randox Toxicology
• 6.64. R-Biopharm AG
• 6.65. Response Biomedical
• 6.66. Revvity
• 6.67. Roche Diagnostics
• 6.68. SD Biosensor
• 6.69. Siemens Healthineers
• 6.70. Standard BioTools
• 6.71. Sysmex
• 6.72. Tecan
• 6.73. Thermo Fisher Scientific
• 6.74. TOSOH Bioscience
• 6.75. Uniogen
• 6.76. Veramarx
• 6.77. Veredus Laboratories
• 6.78. Vircell
• 6.79. Wantai Biopharm
• 6.80. Werfen
• 6.81. YD Diagnostics
• 6.82. Zhejiang Orient Gene Biotech

7. The Global Market

• 7.1. Global Market by Country
  • 7.1.1. Global Market by Country Table
  • 7.1.2. Global Market by Country Chart
• 7.2. Global Market by Application
  • 7.2.1. Global Market by Application Table
  • 7.2.2. Global Market by Application Segment Growth Chart
  • 7.2.3. Global Market by Application Segment Annual Chart
  • 7.2.4. Global Market by Application Segment Base vs. Final
  • 7.2.5. Global Market by Application Base Year
  • 7.2.6. Global Market by Application Final Year
• 7.3. Global Market by Technology
  • 7.3.1. Global Market by Technology Table
  • 7.3.2. Global Market by Technology Segment Growth Chart
  • 7.3.3. Global Market by Technology Segment Annual Chart
  • 7.3.4. Global Market by Technology Segment Base vs. Final
  • 7.3.5. Global Market by Technology Base Year
  • 7.3.6. Global Market by Technology Final Year
• 7.4. Global Market by Product
  • 7.4.1. Global Market by Product Table
  • 7.4.2. Global Market by Product Segment Growth Chart
  • 7.4.3. Global Market by Product Segment Annual Chart
  • 7.4.4. Global Market by Product Segment Base vs. Final
  • 7.4.5. Global Market by Product Base Year
  • 7.4.6. Global Market by Product Final Year
• 7.5. Global Market by User
  • 7.5.1. Global Market by User Table
  • 7.5.2. Global Market by User Segment Growth Chart
  • 7.5.3. Global Market by User Segment Annual Chart
  • 7.5.4. Global Market by User Segment Base vs. Final
  • 7.5.5. Global Market by User Base Year
  • 7.5.6. Global Market by Application Final Year

8. Global Market by Application

• 8.1. Endocrinology Applications
  • 8.1.1. Endocrinology Applications by Country Table
  • 8.1.2. Endocrinology Applications Growth Chart
• 8.2. Immune Applications
  • 8.2.1. Immune Applications by Country Table
  • 8.2.2. Immune Applications Growth Chart
• 8.3. Oncology Applications
  • 8.3.1. Oncology Applications by Country Table
  • 8.3.2. Oncology Applications Growth Chart
• 8.4. Infectious Disease Applications
  • 8.4.1. Infectious Disease Applications by Country Table
  • 8.4.2. Infectious Disease Applications Growth Chart
• 8.5. Cardiology Applications
  • 8.5.1. Cardiology Applications by Country Table
  • 8.5.2. Cardiology Applications Growth Chart
• 8.6. Other Applications
  • 8.6.1. Other Applications by Country Table
  • 8.6.2. Other Applications Growth Chart

9. Immunoassay by Technology

• 9.1. Enzyme
  • 9.1.1. Enzyme by Country Table
  • 9.1.2. Enzyme Growth Chart
• 9.2. Flourescence
  • 9.2.1. Flourescence by Country Table
  • 9.2.2. Flourescence Growth Chart
• 9.3. Chemiluminescence
  • 9.3.1. Chemiluminescence by Country Table
  • 9.3.2. Chemiluminescence Growth Chart
• 9.4. Nucleic Acid
  • 9.4.1. Nucleic Acid by Country Table
  • 9.4.2. Nucleic Acid Growth Chart
• 9.5. Rapid/POC
  • 9.5.1. Rapid/POC by Country Table
  • 9.5.2. Rapid/POC Growth Chart
• 9.6. Other Technology
  • 9.6.1. Other Technology by Country Table
  • 9.6.2. Other Technology Growth Chart

10. Immunoassay by Product

• 10.1. Instrument
  • 10.1.1. Instrument by Country Table
  • 10.1.2. Instrument Growth Chart
• 10.2. Reagents
  • 10.2.1. Reagents by Country Table
  • 10.2.2. Reagents Growth Chart
• 10.3. Services
  • 10.3.1. Services by Country Table
  • 10.3.2. Services Growth Chart

11. Immunoassay by User

• 11.1. Hospital
  • 11.1.1. Hospital by Country Table
  • 11.1.2. Hospital Growth Chart
• 11.2. Outpatient Lab
  • 11.2.1. Outpatient Lab by Country Table
  • 11.2.2. Outpatient Lab Growth Chart
• 11.3. POC/Other
  • 11.3.1. POC/Other by Country Table
  • 11.3.2. POC/Other Growth Chart

12. Vision of the Future of Immunoassay

13. Appendices

• 13.1. Growth of Approved IVD Test Menu
• 13.2. Growth of Approved Average IVD Test Fee
• 13.3. The Most Used IVD Assays
• 13.4. The Highest Grossing Assays
• 13.5. Laboratory Fees Schedule

관련자료